NCT04473079View on ClinicalTrials.gov

Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

June 17, 2022

Study Completion Date

June 17, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DIETARY_SUPPLEMENT

Lacidofil

Investigational product intake daily for 6 weeks. Co-administration of H. pylori treatment with investigational product the first two weeks only.

DIETARY_SUPPLEMENT

Placebo

Investigational product intake daily for 6 weeks. Co-administration of H. pylori treatment with investigational product the first two weeks only.

Trial Locations (1)

12120

Thammasat University Hospital, Khlong Luang

Sponsors
All Listed Sponsors
lead

Lallemand Health Solutions

INDUSTRY

NCT04473079 - Efficacy and Safety of Lacidofil® STRONG as an Adjuvant for Helicobacter Pylori Treatment in Non-ulcer Dyspepsia | Biotech Hunter | Biotech Hunter